Tissue Engineered Skin Substitutes Market Size & Growth Analysis to 2030

The global tissue-engineered skin substitutes market size is expected to grow at a significant CAGR of around 16% during the forecast period from 2023 to 2030. The growing adoption of skin substitutes in various clinical applications and the development of newer procedures are some major factors driving the industry’s growth. Furthermore, the rising prevalence of various skin disorders, increasing adoption of minimally invasive surgical procedures, growing number of diabetic and vascular ulcer patients, and the growing aging population around the world are further anticipated to fuel the market growth at a significant growth rate. Moreover, the technological advancement in healthcare, strong demand for skin grafts, and the growing prevalence of acute and chronic wounds are anticipated to propel the market growth over the forecast period.

Market Snapshot:

Market Drivers:

Increasing Prevalence of Chronic Wounds: The rising prevalence of chronic wounds, such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers, is a significant driving factor for the tissue-engineered skin substitutes market. Chronic wounds are challenging to heal and often require advanced wound care solutions. Tissue-engineered skin substitutes provide a promising treatment option for promoting wound healing and tissue regeneration in patients with chronic wounds.

Growing Geriatric Population: The aging population worldwide is a major driving factor for the tissue-engineered skin substitutes market. Elderly individuals are more prone to chronic wounds due to age-related factors, compromised immune systems, and underlying health conditions. The demand for tissue-engineered skin substitutes is increasing as the geriatric population continues to grow, driving the need for advanced wound care solutions.

Advancements in Tissue Engineering Technologies: Technological advancements in tissue engineering and regenerative medicine have significantly contributed to the growth of the tissue-engineered skin substitutes market. Researchers and manufacturers have made progress in developing sophisticated biomaterials, scaffolds, and cell culture techniques for producing skin substitutes that closely mimic the structure and function of natural skin. These advancements have improved the effectiveness and clinical outcomes of tissue-engineered skin substitutes, driving their adoption in wound care.

Rising Awareness of Advanced Wound Care: There is an increasing awareness and recognition of the importance of advanced wound care in healthcare settings. Traditional wound care methods may not be sufficient for promoting optimal wound healing, especially in chronic and complex cases. Tissue-engineered skin substitutes offer advanced wound healing capabilities by providing a three-dimensional scaffold that supports cell growth and tissue regeneration. The growing awareness of the benefits of advanced wound care solutions fuels the demand for tissue-engineered skin substitutes.

Favorable Reimbursement Policies: Reimbursement policies and coverage by healthcare insurance providers play a significant role in driving the adoption of tissue-engineered skin substitutes. Favorable reimbursement policies, particularly in developed countries, make tissue-engineered skin substitutes more accessible and affordable for patients. This incentivizes healthcare providers to incorporate these advanced wound care solutions into their treatment protocols, contributing to market growth.

Increasing Incidence of Burn Injuries: Burn injuries are a significant driving factor for the tissue-engineered skin substitutes market. Severe burns often require extensive skin grafting or reconstruction to promote healing and prevent complications. Tissue-engineered skin substitutes offer an alternative or adjunct to traditional autografts or allografts by providing a biomimetic scaffold for the regrowth of new skin tissue. The increasing incidence of burn injuries, particularly in industrial settings and developing countries, drives the demand for tissue-engineered skin substitutes.

Supportive Government Initiatives: Government initiatives and funding support for regenerative medicine and tissue engineering research have a positive impact on the tissue-engineered skin substitutes market. Governments and research organizations invest in developing advanced wound care technologies and tissue-engineered products to address the unmet needs of patients with chronic wounds. These initiatives accelerate the development and commercialization of tissue-engineered skin substitutes, driving market growth.

Increasing Demand for Aesthetic and Cosmetic Procedures: Tissue-engineered skin substitutes also find applications in aesthetic and cosmetic procedures, such as skin grafting for scar revision or reconstruction. The demand for aesthetic procedures is increasing globally, driven by factors like changing beauty standards, increased disposable income, and advancements in cosmetic surgery techniques. Tissue-engineered skin substitutes provide a viable option for improving skin appearance and texture, contributing to their demand in aesthetic and cosmetic procedures.

Market Insights:

The global tissue-engineered skin substitute market is bifurcated into product type, application, and geography. On the basis of product type, the market is further segmented into acellular, cellular allogeneic, cellular autologous, and other skin substitutes. The acellular skin substitutes segment dominated the global market in 2022 and estimated to register the fastest growth rate over the forecast period. The growing use of the product during implant-based skin surgeries due to its low cost, easy availability, and higher preference is estimated to drive the segment growth. Furthermore, the associated with acellular skin substitutes such as less inflammatory response, providing no local or systemic toxicity, and allowing water vapor transmission similar to normal skin, are anticipated to boost segment growth over the forecast period.

On the basis of application, the market is segmented into burn injury, diabetic and vascular ulcers, and others. The diabetic and vascular ulcers segment dominated the global tissue-engineered skin substitutes market in 2022 and is expected to maintain its dominance over the forecast period. The segment growth is attributed to factors that include proven efficacy and physician and patient familiarity with diabetes and ulcer patients. Furthermore, the increasing number of diabetes and ulcer patients, especially in developing countries, and consequently, the need for prompt and accurate treatment, is further expected to drive the growth of this segment.

To know more about the research report, request sample papers

The global tissue engineered skin substitutes market report explores the critical analysis of the industry using key parameters. The report covers investment strategies, need for investment in the industry, and several benefits for the investors. Significantly, this report sets out major changes in the global technical regulations for the market, as well as how economic and non-economic constraints are helping the market to grow. Furthermore, the report analyzes the historic and forecasted market size at the global, regional, and country-level. The report also provides a comprehensive analysis of key investment proposals, competitor positions, porter’s five force analysis, pestel analysis, SWOT analysis, value chain analysis, etc.

The tissue engineered skin substitutes market research report presents the analysis of each segment from 2020 to 2030 considering 2022 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2023 to 2030.

Historical & Forecast Period

• 2020-21 – Historical Year
• 2022 – Base Year
• 2023-2030 – Forecast Period

Market Segmentation:

By Type:

• Acellular Skin Substitutes
• Cellular Allogeneic Skin Substitutes
• Cellular Autologous Skin Substitutes
• Others

By Application:

• Burn Injury
• Diabetic and Vascular Ulcers
• Others

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Regional Analysis:

On the basis of region, North America dominated the global tissue-engineered skin substitutes market in the benchmark year. The technological advancement in the healthcare sector and the growing prevalence of vascular diseases such as venous ulcers, deep vein thrombosis, and lymphedema are some major factors driving the industry growth. Furthermore, the availability of advanced products, favorable reimbursement policies, growing demand for skin substitutes, and the growing elderly population is anticipated to drive market growth in North America. On the flip side, the Asia Pacific is expected to witness the highest growth rate over the forecast period.

Geographically, the tissue-engineered skin substitutes market report comprises dedicated sections centering on the regional market revenue and trends. The tissue-engineered skin substitutes market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The tissue engineered skin substitutes market has been extensively analyzed on the basis of various regional factors such as demographics, gross domestic product (GDP), inflation rate, acceptance, and others. Tissue-engineered skin substitutes market estimates have also been provided for the historical years 2020 & 2021 along with forecasts for the period from 2023 – 2030.

Competitive Assessment:

Some of the major market players operating in the global tissue-engineered skin substitutes market are Acelity L.P., Inc., BSN Medical GmbH, ConvaTec Group plc, Integra LifeSciences Corporation, and Medtronic plc. Companies are exploring markets through expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

• Acelity L.P., Inc. (3M Company)
• BSN Medical GmbH (Essity AB)
• ConvaTec Group plc
• Integra LifeSciences Corporation
• Medtronic plc (Covidien plc)
• Molnlycke Health Care
• Organogenesis Holdings, Inc. (Advanced BioHealing, Inc.)
• Smith & Nephew plc
• Tissue Regenix
• Amarantus BioScience Holdings

Key Questions Answered by Tissue Engineered Skin Substitutes Market Report

• Global tissue engineered skin substitutes market forecasts from 2023-2030
• Regional market forecasts from 2023-2030 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
• Country-level forecasts from 2023-2030 covering 15 major countries from the regions as mentioned above
• Tissue engineered skin substitutes submarket forecasts from 2023-2030 covering the market by product type, application, and geography
• Various industry models such as SWOT analysis, Value Chain Analysis about the market
• Analysis of the key factors driving and restraining the growth of the global, regional, and country-level tissue engineered skin substitutes markets from 2023-2030
• Competitive Landscape and market positioning of top 10 players operating in the market